Literature DB >> 6441701

[Changes in the metastasis of experimental tumors and in the antimetastatic effect of cytostatics in their pharmacological action on adrenergic processes].

I G Veksler, V N Riabukha, M I Smelkova, K P Balitskiĭ.   

Abstract

Different pharmacologic drugs (isadrin, obsidan, phentolamine) changing adrenergic processes are shown to have different effect on the growth and development of lung metastases. An increase in the antimetastatic effect of some cytostatics is also observed in mice with Lewis carcinoma and melanoma B-16 under the influence of isadrin, a stimulator of beta-adrenoreceptors. In authors' opinion, isadrin changes microcirculation in lungs and prevents inhibition of the immune reactivity in animals with metastatic tumours, thus contributing to inhibition of the development and growth of metastases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441701

Source DB:  PubMed          Journal:  Eksp Onkol        ISSN: 0204-3564


  2 in total

1.  The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study.

Authors:  Letizia Porcelli; Marianna Garofoli; Roberta Di Fonte; Livia Fucci; Mariateresa Volpicella; Sabino Strippoli; Michele Guida; Amalia Azzariti
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.379

2.  Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.

Authors:  Jessica M Stiles; Clarissa Amaya; Steven Rains; Dolores Diaz; Robert Pham; James Battiste; Jaime F Modiano; Victor Kokta; Laura E Boucheron; Dianne C Mitchell; Brad A Bryan
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.